AI and Neurological Rare & Neuroimmune Diseases ── 2026-10-31
New papers on neurological rare and neuroimmune diseases and AI, collected from journal feeds, PubMed (searched across all journals) and OpenAlex (a public index used instead of Google Scholar), judged by Jev (an AI that makes language judgements): original research, AI central, which of 9 disease groups, treatment or trials, and then ranked by importance up to a daily limit. Journals are not filtered by impact factor; each paper shows its journal's IF-equivalent (OpenAlex two-year mean citedness) and the date of that value. Each entry shows the full original abstract.
Read by disease: Basic research（0） · ALS（0） · Parkinson's（0） · Hereditary neurodegeneration（0） · Neuromuscular（0） · Multiple sclerosis（1） · NMOSD/MOGAD（0） · Myasthenia gravis（0） · Autoimmune encephalitis/CIDP/GBS（0）
Neurodegeneration and neuroimmunology research and AI
No new qualifying paper for this issue.
ALS: treatment, trials and AI
No new qualifying paper for this issue.
Parkinson's disease and parkinsonism: treatment, trials and AI
No new qualifying paper for this issue.
Hereditary neurodegenerative diseases: treatment, trials and AI
No new qualifying paper for this issue.
Neuromuscular diseases (muscular dystrophy, SMA): treatment, trials and AI
No new qualifying paper for this issue.
Multiple sclerosis: treatment, trials and AI
- Abstract
INTRODUCTION: Pain assessment remains challenging due to its subjective nature and reliance on self-reports. These challenges are particularly relevant for multiple sclerosis (MS) patients, for whom pain is among the most common and fluctuating symptoms, occurring in multiple forms. Wearable sensors combined with machine learning (ML) offer the potential for continuous and more objective pain monitoring by leveraging physiological signals in real-world contexts. METHODS: We monitored 18 MS patients over 48 h using the Empatica E4 wristband to collect photoplethysmography, electrodermal activity, skin temperature, and accelerometer data. Physiological features were extracted from 5-, 10-, and 15-min time windows preceding hourly self-reported pain assessment during waking hours. Univariate associations with pain states were evaluated using linear mixed effects models, correcting for multiple comparisons. For classification purposes, feature selection was performed via recursive feature elimination, and 5 ML algorithms were trained and tested with leave-one-subject-out cross-validation. Model performance was evaluated using the F1 score and the sensitivity-specificity balance. RESULTS: For univariate analysis, after correction, only 2 out of 43 features showed significant differences between pain and no-pain states. For the classification task, models based on 5-min windows generally performed the best. The highest F1 score (0.78) was achieved by a Support Vector Machine using 2 features from 5-min windows, while XGBoost achieved the best sensitivity-specificity balance (0.69/0.68) with 2 features from 15-min windows. CONCLUSION: Wearable physiological signals may contain information relevant to pain-state classification in people with MS. However, these results should be considered preliminary, requiring validation in larger, independent cohorts to establish the robustness and generalizability of the proposed approach.
Journal IF-equivalent: 3.5 (OpenAlex 2-year mean citedness, value as of 2026-10-29, retrieved 2026-10-31; not the official Clarivate IF)Reference: Moscato S, Orlandi S, Pozzi S, Lullini G, Sabattini L, La Porta F, et al. Real-World Classification of Pain States in Multiple Sclerosis Patients using Wearable Sensor Data and Ensemble Machine Learning. Digit Biomark. 2026 Oct 1;10(1):202-15. doi:10.1159/dib/acpag001.Checked: Abstract only
See all 1 Multiple sclerosis papers →
NMOSD and MOGAD: treatment, trials and AI
No new qualifying paper for this issue.
Myasthenia gravis: treatment, trials and AI
No new qualifying paper for this issue.
Autoimmune encephalitis, CIDP and Guillain-Barre syndrome: treatment, trials and AI
No new qualifying paper for this issue.